Abstract
Purpose
To examine whether addition of 18F-fluoro-deoxy-glucose positron emission tomography/computed tomography (FDG-PET/CT) to fine needle aspiration biopsy (FNAB) would improve prediction of thyroid cancer in patients with FNAB-derived follicular neoplasm or atypia, classified according to focal, multifocal, diffuse, or no FDG uptake.
Materials and methods
Consecutive patients with FNAB-derived follicular neoplasm or atypia planned for surgery from September 2013 to March 2016 were prospectively included and considered for analysis. All patients underwent preoperative PET/CT and a clinical head and neck examination, including ultrasound of the neck and the thyroid gland. Patients with obvious signs of thyroid malignancy were excluded from the study. Histology of the surgical specimen was used as reference standard for statistical analysis.
Results
Of the 108 patients included (85 women, median age 53.4 years), 31 (29%) had a thyroid nodule that was histologically verified as malignant. Sensitivity and specificity for PET/CT in detection of thyroid cancer was 79 and 32%, respectively, including a derived positive predictive value (PPV) of 31%, and a negative predictive value (NPV) of 79%. Univariate and multivariate analyses showed no significant increase in the risk of thyroid cancer among patients with focal or multifocal FDG uptake compared to patients with no FDG uptake.
Conclusion
Addition of PET/CT to FNAB did not improve prediction of thyroid cancer in patients with FNAB-derived follicular neoplasm or atypia.
Similar content being viewed by others
References
Danmarks-Statistik (2017) Nøgletal om befolkningen efter bevægelsesart og tid. http://www.statistikbanken.dk/10021. Accessed 9 May 2017
Eriksen J (2017) Årsrapport 2015 for den kliniske kvalitetsdatabase DAHANCA. https://www.sundhed.dk/content/cms/5/39205_dahanca_aarsrapport_2015.pdf. Accessed 16 Apr 2017
Sundhedsstyrelsen (2017) Pakkeforløb for hoved- og halskræft. https://www.sst.dk/da/sygdom-og-behandling/kraeft/pakkeforloeb/~/media/94B4013E3D2D445DAC2494EB1CA194CE.ashx. Accessed 7 Apr 2017
Cibas ES, Ali SZ (2009) The Bethesda system for reporting thyroid cytopathology. Thyroid 19:1159–1165
Yassa L, Cibas ES, Benson CB et al (2007) Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer 111:508–516
Yang J, Schnadig V, Logrono R, Wasserman PG (2007) Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer 111:306–315
Baloch ZW, Fleisher S, LiVolsi VA, Gupta PK (2002) Diagnosis of “follicular neoplasm”: a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol 26:41–44
Cramer H (2000) Fine-needle aspiration cytology of the thyroid: an appraisal. Cancer 90:325–329
Garas G, Okabayashi K, Ashrafian H et al (2013) Which hemostatic device in thyroid surgery? A network meta-analysis of surgical technologies. Thyroid 23:1138–1150
Zhang M, Lin O (2016) Molecular testing of thyroid nodules: a review of current available tests for fine-needle aspiration specimens. Arch Pathol Lab Med 140:1338–1344
Bartolazzi A, Orlandi F, Saggiorato E et al (2008) Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study. Lancet Oncol 9:543–549
de Matos PS, Ferreira AP, de Oliveira Facuri F, Assumpcao LV, Metze K, Ward LS (2005) Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy. Histopathology 47:391–401
Saggiorato E, De Pompa R, Volante M et al (2005) Characterization of thyroid ‘follicular neoplasms’ in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application. Endocr Relat Cancer 12:305–317
Kapoor V, McCook BM, Torok FS (2004) An introduction to PET-CT imaging. RadioGraphics 24:523–543
Soelberg KK, Bonnema SJ, Brix TH, Hegedus L (2012) Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography: a systematic review. Thyroid 22:918–925
Chen W, Parsons M, Torigian DA, Zhuang H, Alavi A (2009) Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging. Nucl Med Commun 30:240–244
Vriens D, de Wilt JH, van der Wilt GJ, Netea-Maier RT, Oyen WJ, de Geus-Oei LF (2011) The role of [18F]-2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature. Cancer 117:4582–4594
Kim TY, Kim WB, Ryu JS, Gong G, Hong SJ, Shong YK (2005) 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope 115:1074–1078
Are C, Hsu JF, Schoder H, Shah JP, Larson SM, Shaha AR (2007) FDG-PET detected thyroid incidentalomas: need for further investigation? Ann Surg Oncol 14:239–247
Chen YK, Ding HJ, Chen KT et al (2005) Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects. Anticancer Res 25:1421–1426
Yi JG, Marom EM, Munden RF et al (2005) Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer. Radiology 236:271–275
Hsieh HLS, Yang B, Chu Y, Chang C, Liu R (2003) The clinical relevance of thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography. Nucl Med Sci 16:53–58
Boerner AR, Voth E, Theissen P, Wienhard K, Wagner R, Schicha H (1998) Glucose metabolism of the thyroid in Graves’ disease measured by F-18-fluoro-deoxyglucose positron emission tomography. Thyroid 8:765–772
Hegedüs L (2004) Clinical practice. The thyroid nodule. N Engl J Med 351:1764–1771
Abadi P, Johansen A, Godballe C, Gerke O, Hoilund-Carlsen PF, Thomassen A (2017) 18F-FDG PET/CT to differentiate malignant necrotic lymph node from benign cystic lesions in the neck. Ann Nucl Med 31:101–108
Kresnik E, Gallowitsch HJ, Mikosch P et al (2003) Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area. Surgery 133:294–299
de Geus-Oei LF, Pieters GF, Bonenkamp JJ et al (2006) 18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results. J Nucl Med 47:770–775
Sebastianes FM, Cerci JJ, Zanoni PH et al (2007) Role of 18F-fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules. J Clin Endocrinol Metab 92:4485–4488
Hales NW, Krempl GA, Medina JE (2008) Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules? Am J Otolaryngol 29:113–118
Traugott AL, Dehdashti F, Trinkaus K et al (2010) Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18F-fluorodeoxyglucose positron emission tomography: interim analysis. World J Surg 34:1247–1253
Kim JM, Ryu JS, Kim TY et al (2007) 18F-fluorodeoxyglucose positron emission tomography does not predict malignancy in thyroid nodules cytologically diagnosed as follicular neoplasm. J Clin Endocrinol Metab 92:1630–1634
Deandreis D, Al Ghuzlan A, Auperin A et al (2012) Is (18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology? Thyroid 22:165–172
Mitchell JC, Grant F, Evenson AR, Parker JA, Hasselgren PO, Parangi S (2005) Preoperative evaluation of thyroid nodules with 18FDG-PET/CT. Surgery 138:1166–1174 discussion 1174 – 1165.
National Comprehensive Cancer Network 2015 (2017) NCCN guidelines: thyroid carcinoma. http://www.nccn.org/professionals/physician_gls/pdf/thyroid.pdf. Accessed 16 May 2017
Cohen MS, Arslan N, Dehdashti F et al (2001) Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery 130:941–946
Kang KW, Kim SK, Kang HS et al (2003) Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab 88:4100–4104
Pagano L, Sama MT, Morani F et al (2011) Thyroid incidentaloma identified by (1)(8)F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance. Clin Endocrinol (Oxf) 75:528–534
Bae JS, Chae BJ, Park WC et al (2009) Incidental thyroid lesions detected by FDG-PET/CT: prevalence and risk of thyroid cancer. World J Surg Oncol 7:63
Kang BJ, O JH, Baik JH, Jung SL, Park YH, Chung SK (2009) Incidental thyroid uptake on F-18 FDG PET/CT: correlation with ultrasonography and pathology. Ann Nucl Med 23:729–737
Pathak KA, Goertzen AL, Nason RW, Klonisch T, Leslie WD (2016) A prospective cohort study to assess the role of FDG-PET in differentiating benign and malignant follicular neoplasms. Ann Med Surg (Lond) 12:27–31
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Ethical considerations
The diagnostic procedures including FNAB, PET/CT, surgical procedure, and final histology were approved by the Regional Ethics Committee and the Danish Data Protection Agency Region of Southern Denmark.
Conflict of interest
This study received no financial or other compensations. The authors declare that there is no conflict of interests regarding the publication of this article.
Rights and permissions
About this article
Cite this article
Nguyen, T.T., Lange, N.G.E., Nielsen, A.L. et al. PET/CT and prediction of thyroid cancer in patients with follicular neoplasm or atypia. Eur Arch Otorhinolaryngol 275, 2109–2117 (2018). https://doi.org/10.1007/s00405-018-5030-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-018-5030-4